PCa-sEVs containing NK cell protein group 2D (NKG2D) ligands decrease NKG2D levels on NK and CD8 + T cells, imparing their cytotoxicity thereby facilitating tumor immune evasion [110]. The gene discussed is CD8A; the disease is neoplasm.